PROSTATE CARCINOMA METASTATIC IN THE BONE
Clinical trials for PROSTATE CARCINOMA METASTATIC IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CARCINOMA METASTATIC IN THE BONE trials appear
Sign up with your email to follow new studies for PROSTATE CARCINOMA METASTATIC IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to slow bone metastases in tough prostate cancer
Disease control OngoingThis study looks at whether adding a radiation drug (radium-223) to standard hormone therapy (enzalutamide) can better control prostate cancer that has spread to bone. About 30 men with castration-resistant prostate cancer will be randomly assigned to get enzalutamide alone or wi…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New Triple-Drug cocktail aims to stall spread of prostate cancer
Disease control OngoingThis study tests a combination of three drugs (abiraterone, prednisone, and apalutamide) in 60 men with prostate cancer that has spread but hasn't yet been treated with hormone therapy. The goal is to see how long men can stay on treatment and how well it controls the cancer. Par…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New combo therapy zaps spine tumors before they paralyze
Disease control OngoingThis study tests a combination of two treatments—heat-based tumor destruction (thermal ablation) and precise high-dose radiation (stereotactic radiosurgery)—for people whose cancer has spread to the spine and is pressing on the spinal cord. The goal is to control the tumor and pr…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New combo therapy aims to shrink advanced tumors
Disease control OngoingThis study tests the safety and effectiveness of combining the immunotherapy drug avelumab with other treatments (utomilumab, anti-OX40 antibody, and radiation) in people with advanced cancers that have spread. About 173 adults whose cancer has not responded to standard therapies…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Immunotherapy plus chemo shows promise against Tough-to-Treat cancers
Disease control OngoingThis early-phase trial studies whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help people with rare, aggressive small cell or neuroendocrine cancers of the bladder or prostate. About 15 participants with cancer that has spread will receive the co…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Double-Drug attack shows promise for tough prostate cancer
Disease control OngoingThis study tests whether adding the chemotherapy drug cabazitaxel to the hormone therapy abiraterone works better than abiraterone alone for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapy. About 223 men who have already r…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 11, 2026 20:38 UTC